CoChat

The Drug Etiology of Agranulocytosis and Aplastic Anemia

· 1992 · Annals of Internal Medicine
Cited by 198

The DOI matches its Crossref record.

Abstract

DRUG INDUCED AGRANULOCYTOSIS AND APLASTIC ANEMIA: GENERAL CONSIDERATIONS: The concept of drug safety Agranulocytosis and aplastic anemia as drug-induced diseases Evidence for the drug induction of agranulocytosis Evidence for the drug induction of aplastic anemia STRATEGIES FOR OBTAINING INFORMATION ABOUT DRUG EFFECTS: Benefit, risk, the present study THE DISEASES (by Herman Heimpel): Agranulocytosis, Aplastic anemia THE DESIGN OF THE STUDY: Objectives, definition of cases, study base, sample size estimates, methodological considerations in the collection of data METHODS: Definition and ascertainment of cases, selection of controls, data collection, data analysis THE STUDY EXPERIENCE: Origins of the study, pilot study, changes in the study population, completeness of case ascertainment, definition of onset for cases of agranulocytosis, interim analyses THE STUDY POPULATION: Agranulocytosis, Aplastic anemia, Controls, Summary INCIDENCE OF AGRANULOCYTOSIS: The study base: overall incidence, community-acquired agranulocytosis, comments INCIDENCE OF APLASTIC ANEMIA: The study base: overall incidence, incidence according to various factors, comments NONNARCOTIC ANALGESIC AND NONSTEROIDAL ANTI-FLAMMATORY DRUGS The drugs, specific methods, results, summary of results and consideration of validity, comments, conclusion ANTI-INFECTIVE DRUGS: The drugs, specific methods, results, summary of results and consideration of validity, comments, conclusion ANTITHYROID DRUGS: The drugs, specific methods, results, summary of results and considerations of validity, comments, conclusion CARDIOVASCULAR DRUGS AND DIURETICS: The drugs, specific methods, results, summary of results and consideration of validity, comments, conclusion PSYCHOTROPIC DRUGS AND ANTIHISTAMINES: The drugs, specific methods, results, summary of results and consideration of validity, comments, conclusion MISCELLANEOUS DRUGS: The drugs, specific methods, results, summary of results and consideration of validity, comments, conclusion FACTORS OTHER THAN DRUGS: Introduction, specific methods, results, summary of results and consideration of validity, comments, conclusion GENERAL CONCLUSIONS: Risk estimation for diseases with multiple causes Etiologically relevant risk intervals Regional variation of drug-induced agranulocytosis The strengths and limitations of the present study Concluding remarks. Appendices Index of Drug names.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-12-1072_6

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 198

Metadata

Venue
Annals of Internal Medicine
Published
1992-12-15
Volume
117
Issue
12
Pages
1072-1072
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W615632527
Cited by
198
References
0
FWCI
4.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Drug Etiology of Agranulocytosis and Aplastic Anemia. https://app.cochat.ai/papers/10.7326/0003-4819-117-12-1072_6
The paper
The Drug Etiology of Agranulocytosis and Aplastic Anemia. (1992). Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-117-12-1072_6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.